BridgeMD
New treatment option for Opioid Use
Official title Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
ClinicalTrials.gov ID: NCT07213635
What this study is testing
What is Bupivacaine-epinephrine?
Bupivacaine-epinephrine is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for opioid use.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of the study to see if giving a numbing medicine around the cervix (called a paracervical block) during vaginal hysterectomy with prolapse repair helps people feel less pain and need fewer strong pain medicines afterward. The main question it aims to answer is: Does receiving a paracervical block at the time of vaginal hysterectomy with prolapse repair reduce postoperative opioid use?
- Phase 4: studies an already-approved treatment
- Time commitment: about 6 weeks
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Individuals undergoing vaginal hysterectomy with concomitant prolapse repair procedure
You likely can't join if
- Non-English speaking
- Weight less than 50 kg
- Allergy to bupivacaine
- Pregnant
The study team makes the final eligibility decision.
Where it's taking place
- Raleigh, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Raleigh, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.